Indietro

Selezionare la regione

Azienda

Richiedi un consulto sulle cellule staminali

Per saperne di più

I nostri
trapianti

Elenco degli utilizzi delle cellule staminali approvati dai laboratori del gruppo FamiCord:

Immagine
Elenco degli utilizzi delle cellule staminali approvati dai laboratori del gruppo FamiCord:
Nr. Fonte Tipo di fonte Diagnosi Settore medico Anno di applicazione Terapia Paese Età del destinatario
1901 Apheresis Allogeneic Acute myeloid leukemia Hematology 2024 Standard Therapy Germany 64
1902 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 56
1903 Apheresis Autologous Hodgkin Lymphoma Hematology 2024 Standard Therapy Germany 56
1904 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 64
1905 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 56
1906 Apheresis Autologous Follicular lymphoma Hematology 2024 Standard Therapy Germany 58
1907 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 65
1908 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 47
1909 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 69
1910 Apheresis Autologous Hodgkin Lymphoma Hematology 2024 Standard Therapy Germany 38
1911 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 65
1912 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 70
1913 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 64
1914 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 53
1915 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 60
1916 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 59
1917 Apheresis Autologous Mantle cell lymphoma Hematology 2024 Standard Therapy Germany 45
1918 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 66
1919 Apheresis Autologous Hodgkin Lymphoma Hematology 2024 Standard Therapy Germany 33
1920 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 64
1921 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 59
1922 Apheresis Allogeneic Primary myelofibrosis Hematology 2024 Standard Therapy Germany 55
1923 Apheresis Allogeneic Acute myeloid leukemia Hematology 2024 Standard Therapy Germany 63
1924 Apheresis Allogeneic Blastic Plasmacytoid Dendritic Hematology 2024 Standard Therapy USA 57
1925 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 32
1926 Apheresis Allogeneic Macrofocal multiple myeloma  Hematology 2024 Standard Therapy USA 75
1927 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy United Kingdom 62
1928 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy USA 52
1929 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Germany 48
1930 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy United Kingdom 71
1931 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Romania 35
1932 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Lithuania 47
1933 Apheresis Allogeneic Diffuse large B-cell lymphoma Hematology 2024 Standard Therapy Australia 46
1934 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy USA 65
1935 Apheresis Allogeneic Chronic lymphatic leukemia Hematology 2024 Standard Therapy Norway 52
1936 Apheresis Allogeneic Chronic myelogenous leukemia Hematology 2024 Standard Therapy Poland 60
1937 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Hungary 32
1938 Apheresis Allogeneic Malignant histiocytosis Hematology 2024 Standard Therapy Bulgaria 41
1939 Apheresis Allogeneic Myelodysplastic syndrome Hematology 2024 Standard Therapy USA 78
1940 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Hungary 20
1941 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Italy 58
1942 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy Portugal 67
1943 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Italy 63
1944 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Lithuania 19
1945 Apheresis Allogeneic Hodgkin lymphoma Hematology 2024 Standard Therapy Russia 34
1946 Apheresis Allogeneic chronic lymphocytic leukemia Richters Transformation Hematology 2024 Standard Therapy United Kingdom 68
1947 Apheresis Allogeneic Myelodysplasia Hematology 2024 Standard Therapy Sweden 66
1948 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Italy 52
1949 Apheresis Allogeneic Myelodysplasia Hematology 2024 Standard Therapy Lithuania 70
1950 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Germany 72
1951 Apheresis Allogeneic plasma cell leukemia Hematology 2024 Standard Therapy USA 59
1952 Apheresis Allogeneic Fibrolamellar Carcinoma Hematology 2024 Standard Therapy Czechia 41
1953 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Italy 59
1954 Apheresis Allogeneic post-ET Myelofibrose Hematology 2024 Standard Therapy Austria 61
1955 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy USA 55
1956 Apheresis Allogeneic Myeloma Multiplex Hematology 2024 Standard Therapy Poland 67
1957 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Spain 45
1958 Apheresis Allogeneic Myelofibrose Hematology 2024 Standard Therapy Spain 69
1959 Apheresis Allogeneic Myelofibrose Hematology 2024 Standard Therapy Poland 60
1960 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy USA 53
1961 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy France 35
1962 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Italy 69
1963 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Norway 18
1964 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Germany 51
1965 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy Poland 62
1966 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Hungary 56
1967 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2024 Standard Therapy USA 19
1968 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy Spain 67
1969 Apheresis Allogeneic Hemophagocytic Lymphohistiocytosis Hematology 2024 Standard Therapy United Kingdom 48
1970 Apheresis Allogeneic Non-Hodgkin's lymphoma Hematology 2024 Standard Therapy NETHERLANDS 61
1971 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Germany 29
1972 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 62
1973 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2024 Standard Therapy Israel 63
1974 Apheresis Allogeneic ETP-Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 35
1975 Apheresis Allogeneic Hodgkin lymphoma Hematology 2024 Standard Therapy Poland 4
1976 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy Germany 23
1977 Apheresis Allogeneic Fanconi Anemia Hematology 2024 Standard Therapy USA 27
1978 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy USA 69
1979 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy USA 44
1980 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 49
1981 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy USA 20
1982 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy France 50
1983 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy USA 74
1984 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Austria 49
1985 Apheresis Allogeneic Post-PV Myelofibrose Hematology 2024 Standard Therapy Germany 59
1986 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy USA 66
1987 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 58
1988 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Germany 55
1989 Apheresis Allogeneic Myelofibrosis Hematology 2024 Standard Therapy France 70
1990 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy France 54
1991 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy USA 68
1992 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy Poland 41
1993 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2024 Standard Therapy USA 31
1994 Apheresis Allogeneic Other leukemia Hematology 2024 Standard Therapy Italy 31
1995 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Sweden 42
1996 Apheresis Allogeneic Acute myeloid leukemia Hematology 2024 Standard Therapy Germany 43
1997 Apheresis Allogeneic Acute myeloid leukemia Hematology 2024 Standard Therapy Germany 52
1998 Apheresis Allogeneic Acute myeloid leukemia Hematology 2024 Standard Therapy Germany 64
1999 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 60
2000 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 70